# Evaluation of Adhesion Quality and Irritation of an Alternate Second Generation Estradiol Transdermal System

> **NCT00650442** · PHASE1 · COMPLETED · sponsor: **Mylan Pharmaceuticals Inc** · enrollment: 39 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Estradiol Transdermal System Placebo - Alternate Adhesive
- **DRUG:** Estradiol Transdermal System Placebo - Current Adhesive

## Key facts

- **NCT ID:** NCT00650442
- **Lead sponsor:** Mylan Pharmaceuticals Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-01
- **Primary completion:** 2003-02
- **Final completion:** 2003-02
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2008-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00650442

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00650442, "Evaluation of Adhesion Quality and Irritation of an Alternate Second Generation Estradiol Transdermal System". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00650442. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*